The leaders of Medtronic's neuromodulation business expect the business to take advantage of its extensive engineering and science capabilities and market leadership position to continue addressing unmet needs across a variety of neurological conditions.
Medtronic has been the market leader in neuromodulation since it introduced deep brain stimulation therapy in the 1990s. It currently controls about 76% of the deep-brain stimulation market, which...